Last reviewed · How we verify
Follitropin beta injection 300 IU — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Follitropin beta injection 300 IU (Follitropin beta injection 300 IU) — ART Fertility Clinics LLC.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Follitropin beta injection 300 IU TARGET | Follitropin beta injection 300 IU | ART Fertility Clinics LLC | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Follitropin beta injection 300 IU CI watch — RSS
- Follitropin beta injection 300 IU CI watch — Atom
- Follitropin beta injection 300 IU CI watch — JSON
- Follitropin beta injection 300 IU alone — RSS
Cite this brief
Drug Landscape (2026). Follitropin beta injection 300 IU — Competitive Intelligence Brief. https://druglandscape.com/ci/follitropin-beta-injection-300-iu. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab